Every year, our scientists and patient advisory group identify the studies and topics creating the most impact for people living with arthritis.
Uncover Our Focus for 2026Ongoing and completed studies across our full research portfolio, from prevention and treatment to care and health systems.
Explore Our ResearchMeet the scientists, clinicians, trainees, and patient advisory board members, driving discoveries
Meet Our TeamPeople living with arthritis guide our research priorities, shape study design, and ensure our work reflects real life.
Support Arthritis Research Canada with your time and skills. Whether you want to help at an event or host your own, there is a place for you here.
Living with arthritis? Explore open studies looking for participants and help shape the future of arthritis care.
Your experience with arthritis matters. Sharing it helps others feel less alone and brings the human reality of arthritis into everything we do.
Execution of Research
Using a population-based database that includes all people living in British Columbia, we looked at the rate of venous thromboembolism (blood clots) in patients diagnosed with GPA compared to the general population (people who did not have GPA).
Patients with granulomatosis with polyangiitis (GPA, formerly known as Wegener’s disease) have a much higher risk of blood clots in the lungs and legs. For GPA patients, it is recommended more attention should be given to monitor for these complications, especially early after diagnosis.